Related Experiment Video
Updated: Jul 30, 2025
Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
Published on: December 9, 2022
KCCs, NKCCs, and NCC: Potential targets for cardiovascular therapeutics? A comprehensive review of cell and region
Akshat D Modi1, Areej Naim Khan2, Wing Yan Elizabeth Cheng3
1Department of Biological Sciences, University of Toronto, Scarborough, Ontario M1C 1A4, Canada; Department of Genetics and Development, Krembil Research Institute, Toronto, Ontario M5T 0S8, Canada.
Insights
Cation-chloride cotransporters like KCCs, NKCCs, and NCCs are vital for heart function. Their altered activity contributes to cardiovascular diseases, impacting contractility and arrhythmogenesis.
Area of Science:
- Physiology
- Cardiology
- Molecular Biology
Background:
- Cardiovascular diseases are linked to altered cation-chloride cotransporter function.
- These transporters (KCCs, NKCCs, NCCs) are crucial for cellular homeostasis and physiological processes.
- Dysregulation of these transporters contributes to conditions like cardiac arrhythmia and hypertrophic cardiomyopathy.
Purpose of the Study:
- To review the structure and function of KCC, NKCC, and NCC families.
- To explore their roles in human physiology and cardiac pathobiology.
- To detail cell- and region-specific expression patterns in the heart.
Main Methods:
- Narrative review of existing literature.
- Analysis of physiological and pathophysiological roles.
- Compilation of expression data across 21 cell types and 6 heart regions.
Main Results:
- KCC family members (KCC2, KCC3, KCC4) influence cardiac contractility, vascular resistance, and ischemia response.
- NKCC1 and NCC are critical for vascular smooth muscle tone, blood pressure regulation, and aneurysm formation.
- Specific expression patterns of KCCs, NKCCs, and NCCs exist across different cardiac cell types and regions.
Conclusions:
- Cation-chloride cotransporters are key players in cardiovascular health and disease.
- Understanding their specific roles and expression is crucial for developing therapeutic strategies.
- This review consolidates essential knowledge on these transporters in cardiac function and dysfunction.
Abstract:
Cardiovascular diseases, the leading life-threatening conditions, involve cardiac arrhythmia, coronary artery disease, myocardial infarction, heart failure, cardiomyopathy, and heart valve disease that are associated with the altered functioning of cation-chloride cotransporters. The decreased number of cation-chloride cotransporters leads to reduced reactivity to adrenergic stimulation. The KCC family is crucial for numerous physiological processes including cell proliferation and invasion, regulation of membrane trafficking, maintaining ionic and osmotic homeostasis, erythrocyte swelling, dendritic spine formation, maturation of postsynaptic GABAergic inhibition, and inhibitory/excitatory signaling in neural tracts. KCC2 maintains intracellular chlorine homeostasis and opposes β-adrenergic stimulation-induced Cl- influx to prevent arrhythmogenesis. KCC3-inactivated cardiac tissue shows increased vascular resistance, aortic distensibility, heart size and weight (i.e. hypertrophic cardiomyopathy). Due to KCC4's high affinity for K+, it plays a vital role in cardiac ischemia with increased extracellular K+. The NKCC and NCC families play a vital role in the regulation of saliva volume, establishing the potassium-rich endolymph in the cochlea, sodium uptake in astrocytes, inhibiting myogenic response in microcirculatory beds, regulation of smooth muscle tone in resistance vessels, and blood pressure. NKCC1 regulates chlorine homeostasis and knocking it out impairs cardiomyocyte depolarization and cardiac contractility as well as impairs depolarization and contractility of vascular smooth muscle rings in the aorta. The activation of NCC in vascular cells promotes the formation of the abdominal aortic aneurysm. This narrative review provides a deep insight into the structure and function of KCCs, NKCCs, and NCC in human physiology and cardiac pathobiology. Also, it provides cell-specific (21 cell types) and region-specific (6 regions) expression of KCC1, KCC2, KCC3, KCC4, NKCC1, NKCC2, and NCC in heart.
More Related Videos
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...